Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Epilepsies, Partial: later-stage trial registry
A small indexed set (5 trials) with no open enrollment listed right now.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · none currently recruiting · #3,391 of 28,707 conditions by registered trial count
Epilepsies, Partial: 5 US clinical trials tracked, none currently recruiting.
Epilepsies, Partial is the subject of 5 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 2 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Pfizer's Upjohn has merged with Mylan to form Viatris, running 2 of these trials.
Enrollment posture brief
Registry condition epilepsies-partial
OPEN 0 | RECR 0% | LATE 2 | EARLY 1 | RANK #3391 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Epilepsies, Partial has no open enrollment in this registry pull (5 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Epilepsies, Partial on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Epilepsies, Partial is recruiting below its size-band peers.
0 of 5 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Epilepsies, Partial research.
Pfizer's Upjohn has merged with Mylan to form Viatris accounts for 2 of 5 trials (40%). 4 distinct sponsors appear on at least one study for this condition label.
-
Most Epilepsies, Partial trials plan to enrol fewer than 100 people.
Median target enrolment is 54 among the 5 trials that report a genuine target (sentinel values excluded). 4 of those (80%) plan for fewer than 100 participants.
-
Epilepsies, Partial research is mostly interventional.
5 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Indexed trials (enrollment closed)
5 total, page 1 of 1
Transcranial Direct Current to Treat Epilepsy at Home
Stanford University
NCT04309812
Pediatric Epilepsy Study
Novartis Pharmaceuticals
NCT00050934
Safety, Tolerability, and Pharmacokinetic Study of Pregabalin in Pediatric Patients With Partial Onset Seizures
Pfizer's Upjohn has merged with Mylan to form Viatris
NCT00437281
Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures
Pfizer's Upjohn has merged with Mylan to form Viatris
NCT00448916
Microburst Vagus Nerve Stimulator (VNS) Therapy Feasibility Study
LivaNova
NCT03446664
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 3 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Epilepsies, Partial records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Epilepsies, Partial trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Epilepsies, Partial page
5 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Epilepsies, Partial trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Pfizer's Upjohn has merged with Mylan to form Viatris sponsors the most Epilepsies, Partial trials on record, review their full trial history before evaluating a specific study. See Pfizer's Upjohn has merged with Mylan to form Viatris's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Epilepsies, Partial condition card totals 5 registered trials; most-linked intervention Pregabalin; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.